InMed Pharmaceuticals Inc.
INMNasdaqCIK 1728328HealthcareFiscal year ends Jun 30
Reports and events: 220 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-09-1817:11 ET | 8-K | 3.01 Delisting notice; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-101492 |
| 2026-09-0916:31 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001213900-26-098419 |
| 2026-07-2216:28 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-080414 |
| 2026-07-1016:02 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-077127 |
| 2026-06-1021:32 ET | SCHEDULE 13D | Ownership report, active investor | 0001213900-26-067514 |
| 2026-06-1006:01 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-003132 |
| 2026-05-1910:32 ET | 8-K | 1.01 Entry into a material agreement; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-058795 |
| 2026-05-1906:03 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001062993-26-002787 |
| 2026-05-0718:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-002371 |
| 2026-05-0617:25 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001213900-26-052920 |
| 2026-04-2716:58 ET | 8-K | 1.01 Entry into a material agreement; 3.03 Change to security holders’ rights; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-048064 |
| 2026-04-0316:19 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-039943 |
| 2026-03-3017:37 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001062993-26-001697 |
| 2026-03-2307:31 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-001567 |
| 2026-03-0907:43 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-001347 |
| 2026-03-0616:58 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-024752 |
| 2026-02-1220:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-26-000819 |
| 2026-02-1117:04 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001213900-26-014996 |
| 2025-12-1811:55 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001062993-25-017390 |
| 2025-12-1509:32 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-121497 |
| 2025-11-1916:28 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-112644 |
| 2025-11-0616:06 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001213900-25-107152 |
| 2025-11-0308:00 ET | DEF 14A | Proxy statementPeriod 2025-12-17 | 0001213900-25-104914 |
| 2025-10-2416:05 ET | 10-K/A | Annual report, amendedPeriod 2025-06-30 | 0001213900-25-102157 |
| 2025-10-1616:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-099529 |
| 2025-10-1419:50 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-098229 |
| 2025-10-1417:40 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-098205 |
| 2025-09-2317:24 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-090715 |
| 2025-09-2317:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-090695 |
| 2025-09-2317:46 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001213900-25-090210 |
| 2025-09-0819:25 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-085213 |
| 2025-08-0117:55 ET | S-1/A | Registration statement, amended | 0001213900-25-070112 |
| 2025-07-2815:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-068190 |
| 2025-07-0917:27 ET | S-1 | Registration statement | 0001213900-25-062428 |
| 2025-06-3016:16 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-059673 |
| 2025-06-2414:35 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-057139 |
| 2025-06-1316:30 ET | 8-K | 1.01 Entry into a material agreement; 4.01 Change of auditor; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001213900-25-054315 |
| 2025-05-1617:15 ET | DEF 14A | Proxy statementPeriod 2025-06-13 | 0001213900-25-044948 |
| 2025-05-1306:19 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-042251 |
| 2025-05-1217:27 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001213900-25-042126 |
| 2025-04-2517:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-035646 |
| 2025-04-0817:40 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-25-029501 |
| 2025-02-1414:56 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-014154 |
| 2025-02-1309:38 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-013204 |
| 2025-02-1217:30 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001213900-25-013063 |
| 2025-02-0311:20 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-009213 |
| 2025-01-2210:18 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-005263 |
| 2025-01-2110:54 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-25-004873 |
| 2024-12-3012:16 ET | S-1/A | Registration statement, amended | 0001213900-24-113340 |
| 2024-12-2317:16 ET | S-1 | Registration statement | 0001213900-24-111992 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 04:34 ET. Listed shows no prices and gives no investment advice.